Skip to main navigation Skip to search Skip to main content
Lisa Higgins

View Scopus Profile

Lisa Higgins

Dr

 https://orcid.org/0000-0001-8295-7559

Accepting PhD Students

PhD projects

https://www.monash.edu/medicine/research/supervisorconnect

20052026

Research activity per year

Personal profile

Biography

Alisa (Lisa) Higgins leads the Health Economics Program and is a Senior Research Fellow at the Australian and New Zealand Intensive Care Research Centre, Monash University. She is an NHMRC Emerging Leader Fellow, co-Chair of the Australian Clinical Trials Alliance (ACTA) Health Economics Alongside Trials (HEAT) Group, and an honorary Senior Research Fellow at the George Institute for Global Health. She is also a member of the Research Australia Health Economics Working group, the Australian Health Economics Society, and the Health Services Research Association of Australian and New Zealand. Lisa completed her PhD in 2019 titled ‘An economic evaluation of resuscitation in sepsis’, and also has an MPH majoring in epidemiology and biostatistics, a Graduate Diploma in Biostatistics and a Bachelor of Physiotherapy (Honours).

Lisa has been conducting clinical trials and health economics research for more than 15 years. Her research focuses on evaluating long-term outcomes following ICU, the costs of care in critical illness, and conducting economic evaluations alongside clinical trials in critical care. She has extensive experience in clinical trial methodology, long-term outcomes and health economics. Lisa also has extensive experience in adaptive platform trials, having being involved in the REMAP-CAP trial since its inception, leading its data coordination team throughout the pandemic and leading both the health economics and long-term outcomes globally. She also leads the health economics for the RECOMMEND, STRAP and PROMPT adaptive platform trials.

Lisa is a leader in the field and has authored more than 140 publications with over 14,000 citations and has multiple clinical trial publications in high impact journals including the New England Journal of Medicine and the Journal of the American Medical Association. Notable publications include “Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial” in The Journal of the American Medical Association (JAMA); and “Economic evaluations for intensive care unit randomised clinical trials in Australia and New Zealand: Practical recommendations for researchers” in Australian Critical Care.

Lisa has received over $60 million in competitive grant funding and has served as a member of the management committees of 23 large-scale international randomised controlled NHMRC/MRFF trials.

Education/Academic qualification

Critical Care/Economic Evaluations, PhD, An economic evaluation of resuscitation in sepsis

Award Date: 12 May 2020

Physiotherapy, BPhysio(Hons)

Biostatistics, GradDipBiostat

Public Health, MPH

External positions

Honorary Senior Research Fellow, George Institute for Global Health (Australia)

Research area keywords

  • Critical care
  • Health economics
  • Clinical trials
  • Intensive Care
  • Cost-effectiveness

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 7 - Affordable and Clean Energy
    SDG 7 Affordable and Clean Energy
  3. SDG 12 - Responsible Consumption and Production
    SDG 12 Responsible Consumption and Production
  4. SDG 13 - Climate Action
    SDG 13 Climate Action

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Precision medicine Adaptive Network Platform Trial in Hypoxemic acute respiratory failure PANTHER

    Burrell, A. (Primary Chief Investigator (PCI)), Hodgson, C. (Chief Investigator (CI)), Nichol, A. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Webb, S. (Chief Investigator (CI)), Serpa Neto, A. (Chief Investigator (CI)), Ridley, E. (Chief Investigator (CI)), Fraser, J. (Chief Investigator (CI)), Ryan, L. (Chief Investigator (CI)), Charles-Nelson, A. (Chief Investigator (CI)), Milford, E. (Chief Investigator (CI)), Andersen, C. R. (Chief Investigator (CI)), McAuley, D. F. (Chief Investigator (CI)), Bartlett, S. (Associate Investigator (AI)), White, K. C. (Associate Investigator (AI)) & Wood, A. (Associate Investigator (AI))

    1/03/26 → 7/03/31

    Project: Research

  • PROTECTION economic evaluation

    Higgins, L. (Primary Chief Investigator (PCI)), Fagery, M. (Chief Investigator (CI)) & Bellomo, R. (Chief Investigator (CI))

    8/12/25 → 7/12/26

    Project: Research

  • Healthcare Environmental Sustainability: Creating the evidence to drive adoption of high value initiatives in Australian Hospitals

    McGain, F. (Primary Chief Investigator (PCI)), Best, S. (Chief Investigator (CI)), Buising, K. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Monty, J. (Chief Investigator (CI)), McAlister, S. (Chief Investigator (CI)), Kainer, M. (Chief Investigator (CI)), Patrick, R. (Chief Investigator (CI)), Sinnott, R. (Chief Investigator (CI)), Walshe, C. (Chief Investigator (CI)), Davies, J. E. (Associate Investigator (AI)), Dunne, B. (Associate Investigator (AI)), Kayak, E. (Associate Investigator (AI)), Kevin, K. (Associate Investigator (AI)), Jamriska, M. (Associate Investigator (AI)), Aye, L. (Associate Investigator (AI)), Charlesworth, K. E. (Associate Investigator (AI)), McGushin, A. (Associate Investigator (AI)), Nguyen, M. (Associate Investigator (AI)) & Johnson, D. F. (Associate Investigator (AI))

    1/05/25 → 1/05/27

    Project: Research

  • (PReVENT-NEURO) : PRophylaxis against VENTilator-associated infections in NEUROlogically injured ICU patients trial

    Delaney, A. (Primary Chief Investigator (PCI)), Myburgh, J. (Chief Investigator (CI)), Hammond, N. (Chief Investigator (CI)), Anderson, C. S. (Chief Investigator (CI)), Young, P. J. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Sherry, N. (Chief Investigator (CI)), Litton, E. (Chief Investigator (CI)), Haines, K. (Chief Investigator (CI)), Talbot, P. (Chief Investigator (CI)), Venkatesh, B. (Associate Investigator (AI)), Finfer, S. (Associate Investigator (AI)), Jenkins, C. (Associate Investigator (AI)), Udy, A. (Associate Investigator (AI)), Knowles, S. (Associate Investigator (AI)), Hadley-Brown, K. (Associate Investigator (AI)), Fitzgerald, E. (Associate Investigator (AI)), Andersen, C. R. (Associate Investigator (AI)), Li, Q. (Associate Investigator (AI)) & Saxena, M. K. (Associate Investigator (AI))

    1/07/24 → 30/06/29

    Project: Research

  • Antithrombotic therapy to ameliorate clinical complications in community acquired pneumonia (ATTACC-CAP)

    McQuilten, Z. (Primary Chief Investigator (PCI)), Tong, S. (Chief Investigator (CI)), Webb, S. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Ryan, L. (Chief Investigator (CI)), Venkatesh, B. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Tran, H. (Chief Investigator (CI)), Zarychanski, R. (Chief Investigator (CI)), McFadyen, J. (Chief Investigator (CI)), Aung, A. K. (Chief Investigator (CI)), Lawler, P. (Chief Investigator (CI)), Winearls, J. (Chief Investigator (CI)) & Burrell, A. (Chief Investigator (CI))

    1/07/24 → 30/06/28

    Project: Research

View all 33 projects
View all 157 research outputs
View all 16 prizes